This test is most useful if any of these apply to you.
If you smoke, vape, work around industrial sterilants, or live somewhere with air quality concerns, your body is constantly cleaning up reactive chemicals you would never see on a standard blood panel. HEMA (2-hydroxyethyl mercapturic acid) is one of the molecules your body excretes after that cleanup, and it gives a direct, recent read on how much you have been exposed.
Unlike most lab tests, this one is not used to diagnose a disease. It is used to quantify a specific kind of chemical load, mostly from ethylene oxide and a small group of related two-carbon reactive compounds. The number tells you how hard your detoxification system has been working in the past day or two.
HEMA is what your body makes after it neutralizes ethylene oxide and certain similar reactive chemicals. The process works like this: a reactive molecule enters your body, attaches to your main internal antioxidant (glutathione), and gets processed into a water-soluble form your kidneys can flush out. HEMA is the urine-ready end product of that pathway.
The chemicals that produce HEMA include ethylene oxide (a sterilizing agent and combustion byproduct), vinyl chloride, 1,2-dibromoethane, and acrylonitrile. Cigarette smoke is by far the most common source for the general population, but occupational exposure (especially among hospital sterilization staff) and certain environmental settings also contribute.
In NHANES data covering 7,416 US adults, smoking 10 to 19 cigarettes per day was linked to 36% higher urinary HEMA, and smoking more than 19 per day pushed HEMA 61% higher compared to people smoking 1 to 9 cigarettes daily. HEMA also tracked closely with serum cotinine, the standard nicotine exposure marker.
HEMA responds quickly when the exposure stops. In 17 adults who quit smoking, urinary HEMA fell roughly 80% within just 3 days of cessation and stayed low across 56 days of abstinence. Few biomarkers move that fast, which is why HEMA is useful for tracking real-time changes in chemical exposure rather than long-term cumulative damage.
In the Shanghai Cohort Study, which followed 18,244 Chinese men for nearly two decades, smokers in the highest tertile of HEMA had about 2 times the lung cancer risk of those in the lowest tertile (odds ratio 1.96, 95% CI 1.06 to 3.60), even after adjusting for how many cigarettes they smoked and for how many years.
Once researchers also adjusted for urinary cotinine (a more precise measure of total nicotine intake), the HEMA association disappeared entirely. The interpretation: HEMA is not an independent driver of lung cancer risk so much as a reflection of how much smoke a person is taking in. People with high HEMA are at higher risk because they have higher overall smoke exposure, not because of HEMA itself.
The result above can read like a contradiction: HEMA predicts lung cancer, then suddenly does not. The framework that resolves this is simple. HEMA is an exposure marker, not a damage marker. It tells you what is going into your body, not what your body has done with it. When you account for the broader signal of nicotine exposure, HEMA stops adding new information because they are measuring overlapping things. This is a feature, not a flaw. It means HEMA is doing exactly what an exposure marker should do.
In a cross-sectional NHANES analysis of 5,211 adults, a panel of 19 urinary VOC metabolites that included HEMA was significantly associated with myocardial infarction (heart attack) risk. HEMA was part of the overall chemical burden score rather than the strongest individual contributor. Other VOC mercapturic acids, particularly from acrolein and styrene, did most of the statistical work.
A case-control study of 745 Chinese school-aged children found that those in the highest quartile of urinary HEMA had about twice the odds of dyslexia (odds ratio 1.97, 95% CI 1.20 to 3.23) compared to the lowest quartile, with a geometric mean of 2.92 ng/mL in dyslexic children versus 2.47 ng/mL in controls. Why this association exists is not yet understood, and the finding has not been replicated.
HEMA is a Tier 3 research marker. There are no consensus clinical cutpoints, no guideline-recommended action levels, and no professional society has endorsed a screening threshold. The values below come from US population data and are best read as orientation, not as a target.
These ranges come from a 1999 reference-value study of 412 US adults using urine measurements normalized to creatinine. Your lab may report different numbers, possibly in different units, and assay methods vary across labs.
| Group | Typical Range | What It Suggests |
|---|---|---|
| US adult non-smokers | Around 1.1 to 1.6 micrograms per gram of creatinine | Background environmental exposure |
| US adult smokers | Notably higher than non-smokers, scaling with cigarettes per day | Active chemical uptake from smoke |
| Children (general population) | Detectable in nearly all individuals | Widespread low-level environmental exposure |
What this means for you: a single HEMA reading is most useful for confirming or quantifying an exposure you already suspect. The number itself does not tell you whether you have a disease. It tells you whether your body is currently processing meaningful amounts of certain reactive chemicals.
Because HEMA changes within days of an exposure shift, a single reading is a snapshot of recent days, not a stable trait. The marker is most useful when you measure it more than once and compare against a known reference point in your own life: before and after quitting smoking, before and after switching from cigarettes to a non-combustible product, before and after changing jobs in a hospital sterilization unit.
A practical cadence: get a baseline, then retest 1 to 2 weeks after any exposure change to confirm the shift, then quarterly if you are actively tracking a behavior change. If your situation is stable, annual testing is enough to flag any new exposure that crept in.
If your HEMA is high and you smoke or vape, the result is essentially confirming what you already know: your body is processing significant amounts of reactive chemicals from inhalation. The action is the obvious one. If your HEMA is high and you do not smoke, the most useful next steps are to look at occupational exposure (sterilization equipment, certain manufacturing settings, working near combustion sources), check whether you live with a smoker or are exposed to secondhand smoke, and consider testing a broader VOC mercapturic acid panel to see whether other chemicals are also elevated.
For someone with a high HEMA result who cannot identify a clear source, an occupational medicine consultation is reasonable. For someone with a known smoking history, the result is best paired with a cardiovascular and pulmonary risk assessment, since chronic smoke exposure affects far more than HEMA can show.
This test is most useful for current and former smokers tracking the effect of quitting or switching products, hospital and industrial workers exposed to ethylene oxide as part of their job, and individuals who suspect environmental chemical exposure they want to quantify. For someone with no known exposure source and no symptoms, HEMA is unlikely to change your management.
Evidence-backed interventions that affect your HEMA level
2-Hydroxyethyl Mercapturic Acid is best interpreted alongside these tests.